GlassScriptPhysician profile
Niraj Badhiwala
NPI 1912346024
$3,037.53
in general payments reported to CMS, 2019-2025
26 companies · $1,326 in 2025
The $1,326 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $328 · 2021: $36.14 · 2022: $165 · 2023: $15.21 · 2024: $1,168 · 2025: $1,326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,762 · Travel and Lodging: $740 · Education: $5.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,762.48 |
| Travel and Lodging | $740.31 |
| Education | $5.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $691.65 | 2024 | |
| Calyxo, INC. | $556.20 | 2025 | Cvac Aspiration System |
| Procept Biorobotics Corporation | $297.38 | 2024-2025 | Aquabeam System |
| Boston Scientific Corporation | $244.65 | 2019-2025 | Spaceoar Vue System - 10ml, Rezum Generator, Lithovue |
| Abbvie INC. | $193.92 | 2019-2025 | |
| Medtronic, INC. | $148.28 | 2025 | Interstim, Emprint |
| Astellas Pharma US INC | $138.78 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $120.60 | 2024-2025 | Adstiladrin |
| Olympus America INC. | $77.86 | 2024-2025 | Itind System |
| Merck Sharp & Dohme LLC | $72.54 | 2022-2025 | Welireg, Keytruda, Keytruda Qlex |
| Coloplast Corp | $68.56 | 2023-2024 | Speedicath |
| Antares Pharma, INC. | $66.69 | 2024-2025 | Xyosted |
| Immunitybio, INC. | $58.26 | 2025 | |
| Blue Earth Diagnostics | $48.92 | 2022 | |
| Sumitomo Pharma America, INC. | $37.19 | 2024-2025 | Orgovyx, Gemtesa |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioprotect Medical, INC. | $31.60 | 2025 | Bioprotect Balloon Implant System |
| Innovation Technologies INC | $24.72 | 2024 | Irrisept |
| Axonics, INC. | $24.23 | 2024 | Bulkamid |
| Bluewind Medical | $22.70 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $21.08 | 2024 | Opdivo |
| Verity Pharmaceuticals INC. | $20.94 | 2025 | Trelstar |
| Janssen Biotech, INC. | $19.94 | 2025 | Erleada |
| Accord Healthcare, INC. | $16.97 | 2024 | |
| Dendreon Pharmaceuticals LLC | $15.24 | 2022 | |
| Valencia Technologies Corporation | $13.07 | 2024 | Ecoin Device Kit |
| Travere Therapeutics, INC. | $5.56 | 2025 | Thiola |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Niraj Badhiwala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.